[1] Chang B, Li B, Huang A, et al.Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013[J]. Alcohol, 2016, 54: 61-65. [2] He TT, Jing J, Bai ZF, et al.Constituent ratio and changing trend of non-infectious liver diseases in the Fifth Medical Center of Chinese PLA General Hospital from 2002 to 2018[J]. J Clin Hepatol(临床肝胆病杂志), 2020, 36(8): 1773-1777. [3] Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury[J]. The American Journal of Gastroenterology, 2014, 109(7): 950-966; quiz 967. [4] Drug-induced Liver Disease Study Group Chinese Society of Hepatology Chinses Medical Association.Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol(临床肝胆病杂志), 2015, 31(11): 1752-1769. [5] Fontana RJ, Hayashi PH, Barnhart H, et al.Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury[J]. The American Journal of Gastroenterology, 2015, 110(10): 1450-1459. [6] Inmaculada MC, Mercedes RD, Beatriz GM, et al.Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury[J]. Journal of Hepatology, 2016, 65(3): 532-542. [7] Andrade RJ.EASL clinical practice guidelines: drug-induced liver injury[J]. Journal of Hepatology, 2019, 70(6): 1222-1261. [8] Yue CY, Yi MM, Cheng WC, et al.CSH guidelines for the diagnosis and treatment of drug-induced liver injury[J]. Hepatol Int, 2017, 11(3): 221-241. [9] Jia BW, Yun Z, Zhao FB, et al.Guidelines for the diagnosis and management of herb-induced liver injury[J]. Chin J Integr Med, 2018, 24(9): 696-706. [10] Liang S, Fan ZP, Nie W, et al.Clinical types and features of chronicity of drug-induced liver injury[J]. J Clin Hepatol(临床肝胆病杂志), 2016, 32(12): 2356-2359. [11] Chalasani N, Bonkovsky HL, Fontana R, et al.Features and outcomes of 899 patients with drug-induced liver injury: The Dilin Prospective Study[J]. Gastroenterology, 2015, 148(7): 1340-1352. [12] Shen T, Liu Y, Shang J, et al.Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241. [13] Fontana RJ, Hayashi PH, Gu J, et al.Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from Onset[J]. Gastroenterology, 2014, 147(1): 96-108. [14] Zhu W, Wang L, Zhao X, et al.Prolonged interval of total bilirubin decline is an early independent predictive factor of chronic persistent drug induced liver injury[J]. Hepatology Research, 2020, 50(2): 224-232. [15] Alonso AO, Andrade RJ.Chronic liver injury induced by drugs and toxins[J]. Journal of Digestive Diseases, 2018, 19(9): 514-521. [16] Jing J, Wang R, Zhao X, et al.Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb-Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China[J]. BMJ Open, 2019, 9(1): 1-11. [17] Jing J, Teschke R.Traditional Chinese medicine and herb-induced liver injury: comparison with drug-induced liver injury[J]. Journal of Clinical and Translational Hepatology, 2018, 6: 57-68. [18] Tai LW, Xin YZ, Chen S, et al.A proposed pathologic sub-classification of drug-induced liver injury[J]. Hepatol Int, 2019, 13(3): 339-351. [19] Hillman L, Gottfried M, Whitsett M, et al.Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury[J]. The American Journal of Gastroenterology, 2016, 111(7): 958-965. [20] Yun Z, Ming N, Jing C, et al.Comparison between Chinese herbal medicine and western medicine‐induced liver injury of 1985 patients[J]. Journal of Gastroenterology and Hepatology, 2016, 31(8): 1476-1482. [21] Gerd AK, Raul JA, Michael M, et al.Drug-induced liver injury: recent advances in diagnosis and risk assessment[J]. Gut, 2017, 66(6): 1154-1164. |